• Keine Ergebnisse gefunden

Publikationen Endokrinologie, Diabetologie und Stoffwechsel Originalarbeiten

Im Dokument leistungsbericht-2016.indd (Seite 55-62)

Adolf C, Asbach E, Dietz AS, Lang K, Hahner S, Quinkler M, Rump LC, Bidlingmaier M, Treitl M, Ladurner R, Beuschlein F, Reincke M. Worsening of lipid metabolism after successful treatment of primary aldosteronism. Endocrine. 2016;54:198-205. (IF 3.131)

Beuschlein F, Jakoby J, Mentz S, Zambetti G, Jung S, Reincke M, Süss R, Hantel C. IGF1-R inhibition and liposomal doxorubicin: Progress in preclinical evaluation for the treatment of adrenocortical carcinoma. Mol Cell Endocrinol. 2016;428:82-8. (IF 3.754)

Burn F, Schirpenbach C, Bidlingmaier M, Reincke M, Vetter D, Weishaupt D, Brockmann JG, Müller MK, Weber M, Dahm F, Nocito A. Left-sided living kidney donation leads to transiently reduced adrenocortical responsiveness. Am J Transplant. Epub 2016 Dec 26. (IF 6.165)

Burrello J, Monticone S, Buffolo F, Lucchiari M, Tetti M, Rabbia F, Mengozzi G, Williams TA, Veglio F, Mulatero P. Diagnostic accuracy of aldosterone and renin measurement by chemiluminescent immunoassay and radioimmunoassay in primary aldosteronism. J Hypertens. 2016;34:920-7. (IF 4.085) Caron PJ, Bevan JS, Petersenn S, Houchard A, Sert C, Webb SM5; PRIMARYS Investigators Group (Collaborator: Schopohl J). Effects of lanreotide Autogel primary therapy on symptoms and quality-of-life in acromegaly: data from the PRIMARYS study. Pituitary. 2016;19:149-57. (IF 2.481)

Chanal M, Chevallier P, Raverot V, Fonteneau G, Lucia K, Monteserin Garcia JL, Rachwan A, Jouanneau E, Trouillas J, Honnorat J, Auger C, Theodoropoulou M, Raverot G. Differential effects of PI3K and dual PI3K/mTOR inhibition in rat prolactin-secreting pituitary tumors. Mol Cancer Ther.

2016;15:1261-70. (IF 5.764)

Chow CK, Islam SM, Farmer A, Bobrow K, Maddision R, Whittaker R, Dale LP, Lechner A, Niessen L, Lear SA, Eapen ZJ, Santo K, Stepien S, Redfern J, Rodgers A. Text2PreventCVD: protocol for a systematic review and individual participant data meta-analysis of text message-based interventions for the prevention of cardiovascular diseases. BMJ Open. 2016;6:e012723. (IF 2.369)

Cuny T, Zeiller C, Bidlingmaier M, Défilles C, Roche C, Blanchard MP, Theodoropoulou M, Graillon T, Pertuit M, Figarella-Branger D, Enjalbert A, Brue T, Barlier A. In vitro impact of pegvisomant on growth hormone-secreting pituitary adenoma cells. Endocr Relat Cancer. 2016;23:509-19. (IF 5.267)

| 55

Wissenschaft Degenhart C, Schneller J, Osswald A, Pallauf A, Riester A, Reiser MF, Reincke M, Beuschlein F.

Volumetric and densitometric evaluation of the adrenal glands in patients with primary aldosteronism.

Clin Endocrinol. Epub 2016 Nov 17. (IF 3.327)

Deutschbein T, Bidlingmaier M, Schopohl J, Strasburger CJ, Petersenn S. Anthropometric factors have significant influence on the outcome of the GHRH-arginine test: establishment of normative data for an automated immunoassay specifically measuring 22 kDa human growth hormone. Eur J Endocrinol. Epub 2016 Dec 8. (IF 4.101)

Dimopoulou C, Leistner SM, Ising M, Schneider HJ, Schopohl J, Rutz S, Kosilek R, Frohner R, Stalla GK, Sievers C. Body image perception in acromegaly is not associated with objective acromegalic changes, but depends on depressive symptoms. Neuroendocrinology. Epub 2016 Jul 25. (IF 3.608) Drey M, Sieber CC, Bertsch T, Bauer JM, Schmidmaier R; FiAT intervention group. Osteosarcopenia is more than sarcopenia and osteopenia alone. Aging Clin Exp Res. 2016;28:895-9. (IF 1.394) Eisenhofer G, Dekkers T, Peitzsch M, Dietz AS, Bidlingmaier M, Treitl M, Williams TA, Bornstein SR, Haase M, Rump LC, Willenberg HS, Beuschlein F, Deinum J, Lenders JW, Reincke M. Mass spectrometry-based adrenal and peripheral venous steroid profiling for subtyping primary aldosteronism. Clin Chem. 2016;62:514-24. (IF 8.008)

Epstein N, Brendel T, Hege I, Ouellette DL, Schmidmaier R, Kiesewetter J. The power of the pen: how to make physicians more friendly and patients more attractive. Med Educ. 2016;50:1214-18. (IF 4.005)

Finan B, Clemmensen C, Zhu Z, Stemmer K, Gauthier K, Müller L, De Angelis M, Moreth K, Neff F, Perez-Tilve D, Fischer K, Lutter D, Sánchez-Garrido MA, Liu P, Tuckermann J, Malehmir M, Healy ME, Weber A, Heikenwalder M, Jastroch M, Kleinert M, Jall S, Brandt S, Flamant F, Schramm KW, Biebermann H, Döring Y, Weber C, Habegger KM, Keuper M, Gelfanov V, Liu F, Köhrle J, Rozman J, Fuchs H, Gailus-Durner V, Hrabě de Angelis M, Hofmann SM, Yang B, Tschöp MH, DiMarchi R, Müller TD. Chemical hybridization of glucagon and thyroid hormone optimizes therapeutic impact for metabolic disease. Cell. 2016;167:843-57. (IF 30.410)

Grützner E, Stirner R, Arenz L, Athanasoulia AP, Schrödl K, Berking C, Bogner JR, Draenert R.

Kinetics of human myeloid-derived suppressor cells after blood draw. J Transl Med. 2016;14:2. (IF 3.786)

Götzberger M, Krueger S, Gärtner R, Reincke M, Pichler M, Assmann G, Mussack T, Zimmermann M, Gülberg V. Comparison of color-Doppler and qualitative and quantitative strain-elastography for differentiation of thyroid nodules in daily practice. Hormones (Athens). 2016;15:197-204. (IF 1.481) Hantel C, Ozimek A, Lira R, Ragazzon B, Jäckel C, Frantsev R, Reincke M, Bertherat J, Mussack T, Beuschlein F. TNF alpha signaling is associated with therapeutic responsiveness to vascular disrupting agents in endocrine tumors. Mol Cell Endocrinol. 2016;423:87-95. (IF 3.754)

Hantel C, Shapiro I, Poli G, Chiapponi C, Bidlingmaier M, Reincke M, Luconi M, Jung S, Beuschlein F. Targeting heterogeneity of adrenocortical carcinoma: Evaluation and extension of preclinical tumor models to improve clinical translation. Oncotarget. 2016;7:79292-304. (IF 5.168)

Hoeflich A, Reyer A, Ohde D, Schindler N, Brenmoehl J, Spitschak M, Langhammer M, Tuchscherer A, Wirthgen E, Renner-Muller I, Wanke R, Metzger F, Bielohuby M, Wolf E. Dissociation of somatic growth, time of sexual maturity, and life expectancy by overexpression of an RGD-deficient IGFBP-2 variant in female transgenic mice. Aging Cell. 2016;15:111-7. (IF 6.714)

Islam SM, Lechner A, Ferrari U, Seissler J, Holle R, Niessen LW. Mobile phone use and willingness to pay for SMS for diabetes in Bangladesh. J Public Health. 2016;38:163-9. (IF 2.125)

56 |


Johar H, Emeny RT, Bidlingmaier M, Kruse J, Ladwig KH. Sex-related differences in the association of salivary cortisol levels and type 2 diabetes. Findings from the cross-sectional population based KORA-age study. Psychoneuroendocrinology. 2016;69:133-41. (IF 4.788)

Jones CM, Mallappa A, Reisch N, Nikolaou N, Krone N, Hughes BA, O'Neil DM, Whitaker MJ, Tomlinson JW, Storbeck KH, Merke DP, Ross RJ, Arlt W. Modified release and conventional glucocorticoids and diurnal androgen excretion in congenital adrenal hyperplasia. J Clin Endocrinol Metab. Epub 2016 Nov 15. (IF 5.445)

Jung S, Nagy Z, Fassnacht M, Zambetti G, Weiss M, Reincke M, Igaz P, Beuschlein F, Hantel C.

Preclinical progress and first translational steps for a liposomal chemotherapy protocol against adrenocortical carcinoma. Endocr Relat Cancer. 2016;23:825-37. (IF 5.267)

Kakadia PM, Schmidmaier R, Völkl A, Schneider I, Huk N, Schneider S, Panzner G, Neidel U, Fritz B, Spiekermann K, Bohlander SK. An ETV6-ABL1 fusion in a patient with chronic myeloproliferative neoplasm: Initial response to Imatinib followed by rapid transformation into ALL. Leuk Res Rep.

2016;6:50-4. (IF -)

Kiesewetter J, Ebersbach R, Tsalas N, Holzer M, Schmidmaier R, Fischer MR. Knowledge is not enough to solve the problems - The role of diagnostic knowledge in clinical reasoning activities. BMC Med Educ. 2016;16:303. (IF 1.572)

Krewer C, Schneider M, Schneider HJ, Kreitschmann-Andermahr I, Buchfelder M, Faust M, Berg C, Wallaschofski H, Renner C, Uhl E, Koenig E, Jordan M, Stalla GK, Kopczak A. Neuroendocrine disturbances one to five or more years after traumatic brain injury and aneurysmal subarachnoid hemorrhage: Data from the German database on hypopituitarism. J Neurotrauma. 2016;33:1544-53.

(IF 5.190)

Lang K, Weber K, Quinkler M, Dietz AS, Wallaschofski H, Hannemann A, Friedrichs N, Rump LC, Heinze B, Fuss CT, Quack I, Willenberg HS, Reincke M, Allolio B, Hahner S. Prevalence of malignancies in patients with primary aldosteronism. J Clin Endocrinol Metab. 2016;101:1656-63. (IF 5.455) Lichtenauer UD, Gerum S, Asbach E, Manolopoulou J, Fourkiotis V, Quinkler M, Bidlingmaier M, Reincke M. The clinical value of salivary aldosterone in diagnosis and follow-up of primary aldosteronism. Horm Metab Res. 2016;48:638-43. (IF 2.268)

Maier F, Demmelmair H, Fugmann M, Hellmuth C, Lechner A, Koletzko B, Uhl O. Contribution of glycerophospholipids and sphingomyelin to the circulating NEFA. Prostaglandins Leukot Essent Fatty Acids. 2016;110:55-61. (IF 2.653)

Monticone S, Satoh F, Dietz AS, Goupil R, Lang K, Pizzolo F, Gordon RD, Morimoto R, Reincke M, Stowasser M, Mulatero P. Clinical management and outcomes of adrenal hemorrhage following adrenal vein sampling in primary aldosteronism. Hypertension. 2016;67:146-52. (IF 6.857)

Moriarty PM, Parhofer KG, Babirak SP, deGoma E, Duell PB, Hohenstein B, Ramlow W, Simha V, Steinhagen-Thiessen E, Thompson PD, Vogt A, von Stritzky B, Du Y, Manvelian G. Alirocumab in patients with heterozygous familial hypercholesterolemia undergoing lipoprotein apheresis:

Rationale and design of the ODYSSEY ESCAPE trial. J Clin Lipidol. 2016;10:627-34. (IF 5.812) Moriarty PM, Parhofer KG, Babirak SP, Cornier MA, Duell PB, Hohenstein B, Leebmann J, Ramlow W, Schettler V, Simha V, Steinhagen-Thiessen E, Thompson PD, Vogt A, von Stritzky B, Du Y, Manvelian G. Alirocumab in patients with heterozygous familial hypercholesterolaemia undergoing lipoprotein apheresis: the ODYSSEY ESCAPE trial. Eur Heart J. 2016;37:3588-95. (IF 19.651) Perez-Rivas LG, Rhayem Y, Sabrautzki S, Hantel C, Rathkolb B, Hrabě de Angelis M, Reincke M, Beuschlein F, Spyroglou A. Genetic characterization of a mouse line with primary aldosteronism. J Mol Endocrinol. Epub 2016 Dec 13. (IF 3.577)

| 57

Wissenschaft Rachinger W, Oehlschlaegel F, Kunz M, Fuetsch M, Schichor C, Thurau S, Schopohl J, Seelos K, Tonn

JC, Kreth FW. Cystic craniopharyngiomas: Microsurgical or stereotactic treatment? Neurosurgery.

Epub 2016 Aug 25. (IF 4.889)

Raffin-Sanson ML, Abiven G, Ritzel K, de Corbière P, Cazabat L, Zaharia R, Groussin L, Libe R, Bertherat J, Fassnacht M, Bertagna X. Corticosurrénalome et grossesse - Adrenocortical carcinoma and pregnancy. Ann Endocrinol (Paris). 2016;77:139-47. (IF 0.866)

Remde H, Dietz A, Emeny R, Riester A, Peters A, de Las Heras Gala T, Then C, Seissler J, Beuschlein F, Reincke M, Quinkler M. The cardiovascular markers copeptin and high-sensitive C-reactive protein decrease following specific therapy for primary aldosteronism. J Hypertens. 2016;34:2066-73. (IF 4.085) Rhayem Y, Perez-Rivas LG, Dietz A, Bathon K, Gebhard C, Riester A, Mauracher B, Gomez-Sanchez C, Eisenhofer G, Schwarzmayr T, Calebiro D, Strom TM, Reincke M, Beuschlein F. PRKACA somatic mutations are rare findings in aldosterone-producing adenomas. J Clin Endocrinol Metab.

2016;101:3010-7. (IF 5.455)

Rodrigues R, Artieda M, Tejedor D, Martínez A, Konstantinova P, Petry H, Meyer C, Corzo D, Sundgreen C, Klor HU, Gouni-Berthold I, Westphal S, Steinhagen-Thiessen E, Julius U, Winkler K, Stroes E, Vogt A, Hardt P, Prophet H, Otte B, Nordestgaard BG, Deeb SS, Brunzell JD. Pathogenic classification of LPL gene variants reported to be associated with LPL deficiency. J Clin Lipidol.

2016;10:394-409. (IF 5.812)

Ronchi CL, Di Dalmazi G, Faillot S, Sbiera S, Assié G, Weigand I, Calebiro D, Schwarzmayr T, Appenzeller S, Rubin B, Waldmann J, Scaroni C, Bartsch DK, Mantero F, Mannelli M, Kastelan D, Chiodini I, Bertherat J, Reincke M, Strom TM, Fassnacht M, Beuschlein F; European Network for the Study of Adrenocortical Tumors (ENSAT). Genetic landscape of sporadic unilateral adrenocortical adenomas without PRKACA p.Leu206Arg mutation. J Clin Endocrinol Metab. 2016;101:3526-38. (IF 5.455) Ronchi CL, Peverelli E, Herterich S, Weigand I, Mantovani G, Schwarzmayr T, Sbiera S, Allolio B, Honegger J, Appenzeller S, Lania AG, Reincke M, Calebiro D, Spada A, Buchfelder M, Flitsch J, Strom TM, Fassnacht M. Landscape of somatic mutations in sporadic GH-secreting pituitary adenomas. Eur J Endocrinol. 2016 Mar;174:363-72. (IF 4.101)

Rosada A, Kassner U, Banisch D, Bender A, Steinhagen-Thiessen E, Vogt A. Quality of life in patients treated with lipoprotein apheresis. J Clin Lipidol. 2016;10:323-9.e6. (IF 5.812)

Sack M, Lenz JN, Jakovcevski M, Biedermann SV, Falfán-Melgoza C, Deussing J, Bielohuby M, Bidlingmaier M, Pfister F, Stalla GK, Sartorius A, Gass P, Weber-Fahr W, Fuss J, Auer MK. Early effects of a high-caloric diet and physical exercise on brain volumetry and behavior: a combined MRI and histology study in mice. Brain Imaging Behav. Epub 2016 Oct 12. (IF 3.985)

Safita N, Islam SM, Chow CK, Niessen L, Lechner A, Holle R, Laxy M. The impact of type 2 diabetes on health related quality of life in Bangladesh: results from a matched study comparing treated cases with non-diabetic controls. Health Qual Life Outcomes. 2016;14:129. (IF 2.143)

Schloot NC, Pham MN, Hawa MI, Pozzilli P, Scherbaum WA, Schott M, Kolb H, Hunter S, Schernthaner G, Thivolet C, Seissler J*, Leslie RD*. Inverse relationship between organ-specific autoantibodies and systemic immune mediators in type 1 diabetes and type 2 diabetes: Action LADA 11. Diabetes Care.

2016;39:1932-39. (IF 11.857) *geteilte Letztautorenschaft

Sinnott RO, Beuschlein F, Eisenhofer G, Gloeckner S, Stell A. Beyond a disease registry: An integrated virtual environment for adrenal cancer research. J Grid Comput. 2016;14:515-32. (IF 2.766)

Stemberger M, Möhnle P, Tschöp J, Ney L, Spannagl M, Reincke M. Successful bleeding control with recombinant porcine factor VIII in reduced loading doses in two patients with acquired haemophilia A and failure of bypassing agent therapy. Haemophilia. 2016;22:e472-4. (IF 3.569)

58 |


Straka C, Liebisch P, Salwender H, Hennemann B, Metzner B, Knop S, Adler-Reichel S, Gerecke C, Wandt H, Bentz M, Bruemmendorf TH, Hentrich M, Pfreundschuh M, Wolf HH, Sezer O, Bargou R, Jung W, Trümper L, Hertenstein B, Heidemann E, Bernhard H, Lang N, Frickhofen N, Hebart H, Schmidmaier R, Sandermann A, Dechow T, Reichle A, Schnabel B, Schäfer-Eckart K, Langer C, Gramatzki M, Hinke A, Emmerich B, Einsele H. Autotransplant with and without induction chemotherapy in older multiple myeloma patients: long-term outcome of a randomized trial.

Haematologica. 2016;101:1398-406. (IF 7.702)

Strasburger CJ, Vanuga P, Payer J, Pfeifer M, Popovic V, Bajnok L, Góth M, Olšovská V, Trejbalová L, Vadasz J, Fima E, Koren R, Amitzi L, Bidlingmaier M, Hershkovitz O, Hart G, Biller BM. MOD-4023, a long-acting carboxy-terminal peptide-modified human growth hormone: results of a Phase 2 study in growth hormone-deficient adults. Eur J Endocrinol. Epub 2016 Dec 8. (IF 4.101)

Strasburger CJ, Karavitaki N, Störmann S, Trainer PJ, Kreitschmann-Andermahr I, Droste M, Korbonits M, Feldmann B, Zopf K, Sanderson VF, Schwicker D, Gelbaum D, Haviv A, Bidlingmaier M, Biermasz NR. Patient-reported outcomes of parenteral somatostatin analogue injections in 195 patients with acromegaly. Eur J Endocrinol. 2016;174:355-62. (IF 4.101)

Störmann S, Stankiewicz M, Raes P, Berchtold C, Kosanke Y, Illes G, Loose P, Angstwurm MW. How well do final year undergraduate medical students master practical clinical skills? GMS J Med Educ.

2016;33:Doc58. (IF -)

Tauber P, Aichinger B, Christ C, Stindl J, Rhayem Y, Beuschlein F, Warth R, Bandulik S. Cellular pathophysiology of an adrenal adenoma-associated mutant of the plasma membrane Ca(2+)-ATPase ATP2B3. Endocrinology. 2016;157:2489-99. (IF 4.286)

Teumer A, Qi Q, Nethander M, Aschard H, Bandinelli S, Beekman M, Berndt SI, Bidlingmaier M, Broer L; CHARGE Longevity Working Group., Cappola A, Ceda GP, Chanock S, Chen MH, Chen TC, Chen YD, Chung J, Del Greco Miglianico F, Eriksson J, Ferrucci L, Friedrich N, Gnewuch C, Goodarzi MO, Grarup N, Guo T, Hammer E, Hayes RB, Hicks AA, Hofman A, Houwing-Duistermaat JJ, Hu F, Hunter DJ, Husemoen LL, Isaacs A, Jacobs KB, Janssen JA, Jansson JO, Jehmlich N, Johnson S, Juul A, Karlsson M, Kilpelainen TO, Kovacs P, Kraft P, Li C, Linneberg A, Liu Y, Loos RJ; Body Composition Genetics Consortium., Lorentzon M, Lu Y, Maggio M, Magi R, Meigs J, Mellström D, Nauck M, Newman AB, Pollak MN, Pramstaller PP, Prokopenko I, Psaty BM, Reincke M, Rimm EB, Rotter JI, Saint Pierre A, Schurmann C, Seshadri S, Sjögren K, Slagboom PE, Strickler HD, Stumvoll M, Suh Y, Sun Q, Zhang C, Svensson J, Tanaka T, Tare A, Tönjes A, Uh HW, van Duijn CM, van Heemst D, Vandenput L, Vasan RS, Völker U, Willems SM, Ohlsson C, Wallaschofski H, Kaplan RC. Genomewide meta-analysis identifies loci associated with IGF-I and IGFBP-3 levels with impact on age-related traits. Aging Cell. 2016;15:811-24. (IF 6.714)

Then C, Rottenkolber M, Lechner A, Meisinger C, Heier M, Koenig W, Peters A, Rathmann W, Bidlingmaier M, Reincke M, Seissler J. Altered relation of the renin-aldosterone system and vasoactive peptides in type 2 diabetes: The KORA F4 study. Atherosclerosis. 2016;252:88-96. (IF 4.239)

Then C, Rottenkolber M, Lechner A, Meisinger C, Heier M, Koenig W, Peters A, Rathmann W, Bidlingmaier M, Reincke M, Seissler J. Dataset of the associations of aldosterone to renin ratio with MR-proANP and MR-proADM. Data Brief. 2016;8:1395-99. (IF -)

Wendler J, Kroiss M, Gast K, Kreissl MC, Allelein S, Lichtenauer U, Blaser R, Spitzweg C, Fassnacht M, Schott M, Führer D, Tiedje V. Clinical presentation, treatment and outcome of anaplastic thyroid carcinoma: results of a multicenter study in Germany. Eur J Endocrinol. 2016;175:521-9. (IF 4.101) Wiedemann T, Bielohuby M, Müller TD, Bidlingmaier M, Pellegata NS. Obesity in MENX rats Is accompanied by high circulating levels of ghrelin and improved insulin sensitivity. Diabetes.

2016;65:406-20. (IF 8.684)

| 59

Wissenschaft Williams TA, Peitzsch M, Dietz AS, Dekkers T, Bidlingmaier M, Riester A, Treitl M, Rhayem Y,

Beuschlein F, Lenders JW, Deinum J, Eisenhofer G, Reincke M. Genotype-specific steroid profiles associated with aldosterone-producing adenomas. Hypertension. 2016;67:139-45. (IF 6.857) Wu Y, Tedesco L, Lucia K, Schlitter AM, Garcia JM, Esposito I, Auernhammer CJ, Theodoropoulou M, Arzt E, Renner U, Stalla GK. RSUME is implicated in tumorigenesis and metastasis of pancreatic neuroendocrine tumors. Oncotarget. 2016;7:57878-93. (IF 5.168)

Wölfel T, Beltermann E, Lottspeich C, Vietz E, Fischer MR, Schmidmaier R. Medical ward round competence in internal medicine - an interview study towards an interprofessional development of an Entrustable Professional Activity (EPA). BMC Med Educ. 2016;16:174. (IF 1.572)

Yuen KC, Frystyk J, Rhoads SA, Bidlingmaier M. Pegvisomant-primed glucagon stimulation test in assessing GH reserve and GH/IGF kinetics in adults suspected of GH deficiency. Pituitary. 2016;19:65-74. (IF 2.481)

Zengin A, Kropp B, Chevalier Y, Junnila R, Sustarsic E, Herbach N, Fanelli F, Mezzullo M, Milz S, Bidlingmaier M, Bielohuby M. Low-carbohydrate, high-fat diets have sex-specific effects on bone health in rats. Eur J Nutr. 2016;55:2307-20. (IF 4.370)

Zhang CJ, Bidlingmaier M, Altaye M, Page LC, D'Alessio D, Tschöp MH, Tong J. Acute administration of acyl, but not desacyl ghrelin, decreases blood pressure in healthy humans. Eur J Endocrinol. Epub 2016 Nov 9. (IF 4.101)

Zheng S, Cherniack AD, Dewal N, Moffitt RA, Danilova L, Murray BA, Lerario AM, Else T, Knijnenburg TA, Ciriello G, Kim S, Assie G, Morozova O, Akbani R, Shih J, Hoadley KA, Choueiri TK, Waldmann J, Mete O, Robertson AG, Wu HT, Raphael BJ, Shao L, Meyerson M, Demeure MJ, Beuschlein F, Gill AJ, Sidhu SB, Almeida MQ, Fragoso MC, Cope LM, Kebebew E, Habra MA, Whitsett TG, Bussey KJ, Rainey WE, Asa SL, Bertherat J, Fassnacht M, Wheeler DA; Cancer Genome Atlas Research Network., Hammer GD, Giordano TJ, Verhaak RG. Comprehensive pan-genomic characterization of adrenocortical carcinoma. Cancer Cell. 2016;29:723-36. (IF 27.407)

Übersichtsarbeiten, Buchbeiträge und Letters

Åkerström T, Carling T, Beuschlein F, Hellman P. Genetics of adrenocortical tumours. J Intern Med.

2016;280:540-50. (IF 7.598)

Allen DB, Backeljauw P, Bidlingmaier M, Biller BM, Boguszewski M, Burman P, Butler G, Chihara K, Christiansen J, Cianfarani S, Clayton P, Clemmons D, Cohen P, Darendeliler F, Deal C, Dunger D, Erfurth EM, Fuqua JS, Grimberg A, Haymond M, Higham C, Ho K, Hoffman AR, Hokken-Koelega A, Johannsson G, Juul A, Kopchick J, Lee P, Pollak M, Radovick S, Robison L, Rosenfeld R, Ross RJ, Savendahl L, Saenger P, Toft Sorensen H, Stochholm K, Strasburger C, Swerdlow A, Thorner M. GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults. Eur J Endocrinol. 2016;174:P1-9. (IF 4.101)

Asbach E, Williams TA, Reincke M. Recent developments in primary aldosteronism. Exp Clin Endocrinol Diabetes. 2016;124:335-41. (IF 1.685)

Bidlingmaier M. Spotting the cheaters. Clin Chem. 2016;62:1296-8. (IF 8.008)

Christiansen JS, Backeljauw PF, Bidlingmaier M, Biller BM, Boguszewski MC, Casanueva FF, Chanson P, Chatelain P, Choong CS, Clemmons DR, Cohen LE, Cohen P, Frystyk J, Grimberg A, Hasegawa Y, Haymond MW, Ho K, Hoffman AR, Holly JM, Horikawa R, Höybye C, Jorgensen JO, Johannsson G, Juul A, Katznelson L, Kopchick JJ, Lee KO, Lee KW, Luo X, Melmed S, Miller BS, Misra M, Popovic V, Rosenfeld RG, Ross J, Ross RJ, Saenger P, Strasburger CJ, Thorner MO, Werner H, Yuen K. Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations. Eur J Endocrinol. 2016;174:C1-8. (IF 4.104)

60 |


Dalmazi GD, Beuschlein F. PRKACA mutations in adrenal adenomas: Genotype/phenotype correlations. Horm Metab Res. 2017;49:301-6. (IF 2.268)

Feldkamp J, Schott M, Gogol M, Quinkler M, Blüher M, Diederich S, Reincke M. Die Klug-entscheiden-Initiative der Deutschen Gesellschaft für Innere Medizin. Empfehlungen der Deutschen Gesellschaft für Endokrinologie und der Deutschen Gesellschaft für Geriatrie. Internist. 2016;57:532-9. (IF 0.406) Fischer MR, Wölfel T, Schmidmaier R. Schnittstelle Visite. Interface ward round. Dtsch Med Wochenschr. 2016;141:28-31. (IF 0.552)

Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, Stowasser M, Young WF Jr. The management of primary aldosteronism: Case detection, diagnosis, and treatment: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2016;101:1889-916. (IF 5.455)

Gärtner R. Recent data on iodine intake in Germany and Europe. J Trace Elem Med Biol. 2016;37:85-9. (IF 3.225)

Hantel C, Beuschlein F. Xenograft models for adrenocortical carcinoma. Mol Cell Endocrinol.

2016;421:28-33. (IF 3.754)

Klancic T, Woodward L, Hofmann SM, Fisher EA. High density lipoprotein and metabolic disease:

Potential benefits of restoring its functional properties. Mol Metab. 2016;5:321-7. (IF 6.799) Klymiuk N, Ludwig B, Seissler J, Reichart B, Wolf E. Current concepts of using pigs as a source for beta-cell replacement therapy of type 1 diabetes. Current Mol Biol Rep. 2016;2:73-82. (IF -)

Ladurner R, Beuschlein F, Hallfeldt K, Angele M, Werner J, Sommerey S. Schilddrüsenknoten: wann operieren?. MMW Fortschr Med. 2016;158:51-4. (IF -)

Maison N, Korpershoek E, Eisenhofer G, Robledo M, de Krijger R, Beuschlein F. Somatic RET mutation in a patient with pigmented adrenal pheochromocytoma. Endocrinol Diabetes Metab Case Rep. 2016;2016:150117. (IF -)

Perez-Rivas LG, Reincke M. Genetics of Cushing's disease: an update. J Endocrinol Invest.

2016;39:29-35. (IF 2.633)

Reincke M. Adrenal vein sampling for subtyping in primary aldosteronism. Lancet Diabetes Endocrinol. 2016;4:718-9. (IF 19.742)

Reincke M, Lehnert H. Osteologie 2016: Mehr als nur Osteoporose. Internist. 2016;57:629-30. (IF 0.406) Saeger W, Honegger J, Theodoropoulou M, Knappe UJ, Schöfl C, Petersenn S, Buslei R. Clinical impact of the current WHO classification of pituitary adenomas. Endocr Pathol. 2016;27:104-14. (IF 1.936) Saeger W, Petersenn S, Schöfl C, Knappe UJ, Theodoropoulou M, Buslei R, Honegger J. Emerging histopathological and genetic parameters of pituitary adenomas: Clinical impact and recommendation for future WHO classification. Endocr Pathol. 2016;27:115-22. (IF 1.936)

Schilbach K, Schopohl J. Update on the use of oral octreotide therapy for acromegaly. Expert Rev Endocrinol Metab. 2016;11:349-355. (IF -)

Störmann S, Schopohl J. Perspectives on investigational drugs for acromegaly. Expert Opin Investig Drugs. 2016;25:381-4. (IF 4.030)

Vogt A. Lipoproteinapherese - Indikationen, Durchführung und Perspektive. Kardiologe 2016; 10:187-98. (IF -) Vogt A. The Italian Consensus Conferences on low density lipoprotein-cholesterol apheresis. Blood Transfus. 2016;15:1-3. (IF 1.607)

| 61



Mitarbeiterinnen und Mitarbeiter

Prof. Dr. med. Thomas Sitter Priv.-Doz. Dr. med. Volker Vielhauer Dr. med. Hannah Schäfer Dr. med. Sebastian Martini

Doktorandinnen und Doktoranden

Thomas Tröger, Arzt cand. med. Ivana Jureta cand. med. Valerie Hügler

Nichtwissenschaftliche Mitarbeiterinnen und Mitarbeiter

Claudia Blank, Studienassistentin Luciano Andriaccio, Pfleger


Therapie der IgA-Nephritis, Diabetische Nephro-pathie, CKD-Progression, Nierentransplantation Natriumspeicherung bei Niereninsuffizienz, Tuberöse Sklerose

Im Dokument leistungsbericht-2016.indd (Seite 55-62)